01 4Bayer Inc.
02 1Gowling Lafleur Henderson LLP
03 9Gowling WLG (Canada) LLP
04 3Gowlings
05 2Ridout & Maybee LLP
01 31339707
02 31340861
03 11341292
04 21341604
05 12118121
06 12275890
07 12345138
08 12428144
09 12473526
10 52952488
01 2Interferon Alphacon-1
02 3Interferon beta-1a
03 7Interferon beta-1b
04 7PEGINTERFERON BETA-1A
01 1KIT
02 6LIQUID
03 1Lyophilized powder for resonstitution
04 4Lyophilized powder with accompanying diluent
05 3Powder for Solution
06 2Solution for Injection
07 2solution
01 12013-04-14
02 32015-03-10
03 32016-12-28
04 12017-12-23
05 12018-09-18
06 12019-10-15
07 12021-11-07
08 62023-01-17
09 22027-05-04
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Brand Name : BETASERON
Patent Number : 1340861
Filing Date : 1983-10-12
Strength per Unit : 0.3mg per vial (250 ug / mL when reconstituted)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutanous injection
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Brand Name : BETASERON
Patent Number : 1339707
Filing Date : 1986-08-20
Strength per Unit : 0.3mg per vial (250 ug / mL when reconstituted)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutanous injection
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Brand Name : FERONA
Patent Number : 1339707
Filing Date : 1986-08-20
Strength per Unit : 0.3 mg / vial (250 ?g / ml)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2015-03-10
Date Granted : 1998-03-10
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Brand Name : FERONA
Patent Number : 1340861
Filing Date : 1983-10-12
Strength per Unit : 0.3 mg / vial (250 ?g / ml)
Dosage Form : Lyophilized powder with accompanying diluent
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Patent Expiration Date : 2017-12-23
Date Granted : 2011-11-01
Brand Name : AVONEX
Patent Number : 2275890
Filing Date : 1997-12-23
Strength per Unit : 30 mcg / 0.5mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2017-12-23
Date Granted : 2011-11-01
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Brand Name : AVONEX
Patent Number : 1341604
Filing Date : 1981-04-04
Strength per Unit : 30 mcg / 0.5mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intramuscular
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Brand Name : AVONEX
Patent Number : 1341604
Filing Date : 1981-04-04
Strength per Unit : 30 mcg / mL
Dosage Form : Lyophilized powder for resonstitution
Human Or VET : Human
Route of Administration : Intramuscular injection
Patent Expiration Date : 2027-05-04
Date Granted : 2010-05-04
Patent Expiration Date : 2019-10-15
Date Granted : 2009-12-15
Brand Name : PLEGRIDY
Patent Number : 2345138
Filing Date : 1999-10-15
Strength per Unit : 125 ?g / 0.5mL
Dosage Form : LIQUID
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2019-10-15
Date Granted : 2009-12-15
Patent Expiration Date : 2023-01-17
Date Granted : 2013-10-22
Brand Name : PLEGRIDY
Patent Number : 2473526
Filing Date : 2003-01-17
Strength per Unit : 125 ?g / 0.5mL
Dosage Form : LIQUID
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2023-01-17
Date Granted : 2013-10-22
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
Brand Name : EXTAVIA
Patent Number : 1340861
Filing Date : 1983-10-12
Strength per Unit : 0.3 mg / vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2016-12-28
Date Granted : 1999-12-28
